retatrutide fda approval status 2025 Status: July 2026 Update October 27, 2025: U.K. regulators
Description
Typical adverse effects are mild and gastrointestinal
However, any underlying risk factors for microbial overgrowth, such as IBS or prior gut infections, may still be present and can continue to influence SIBO, IMO, or related symptoms
your habits drive sustainable fat loss
.webp)
If following a diabetes-friendly eating plan hasnt adequately controlled blood sugar levels, you may be a good candidate for Ozempic
Way More Accessible Lets be real
Its a natural hormone your gut produces after you eat food to trigger insulin release and tell your brain youre full
